Valeant increased the offer price to acquire all the outstanding common stock of Salix from $158.00 per share to $173.00 per share

GSK has agreed to the sale of 28.2 million ordinary shares in Aspen Pharmacare Holdings

Endo International has submitted a proposal to the Board of Directors of Salix to acquire all of the outstanding shares of common stock of Salix Pharmaceuticals

Concordia Healthcare has entered into a definitive asset purchase agreement to acquire substantially all of the commercial assets of privately held Covis Pharma and Covis Injectables for US$1.2 billion

AbbVie will acquire Pharmacyclics, and its flagship asset Imbruvica (ibrutinib), a highly effective treatment for hematologic malignancies

Mallinckrodt will acquire Ikaria from a Madison Dearborn-led investor group in a transaction valued at approximately $2.3 billion

Baxter has acquired SuppreMol for EUR 200 million (approximately $225M USD) before working capital and other adjustments

Nikon has agreed to buy British retinal imaging firm Optos for 259.3 million pounds

Shire has acquired Meritage for an upfront fee of $70 million and additional contingent payments

Sorin and Cyberonics announced their merger plan to create a new global leader in medical technologies